Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nuedexta in treatment-resistant major depression
NCT01882829Phase 2Completed
- Start
- Jul 2013
- Primary completion
- Mar 2016
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dextromethorphan + quinidine in major depressive disorder (MDD). Started Jul 2013; status: completed.
02
Drugs
dextromethorphan + quinidine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01882829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01882829.